Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
ConclusionCIAC using HD-MTX-based protocols with OBBBD is a safe and well-tolerated procedure for the management of PCNSL. Our data suggests better PFS and survival outcomes compared to IV protocols with less hematologic toxicity and good tolerability, especially in the elderly.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Anemia | Brain | Brain Cancers | Cancer & Oncology | Chemotherapy | Hematology | Lymphoma | Methotrexate | Neurology | Primary CNS Lymphoma | Stroke | Study | Thrombocytopenia | Toxicology